|Governor Thomas G. Thompson||Exec. Chairman||100k||N/A||1942|
|Mr. Hugh O'Dowd M.B.A.||Pres & Director||1.19M||N/A||1965|
|Mr. Robert G. Finizio||Co-Founder||2.53M||N/A||1971|
|Mr. Marlan D. Walker J.D.||Gen. Counsel & Secretay||506.21k||N/A||1975|
|Dr. Brian A. Bernick F.A.C.O.G., M.D.||Co-Founder,Co-CEO & Chief Medical Officer||N/A||N/A||1968|
|Mr. Mark A. Glickman||Co-CEO & Chief Bus. Officer||N/A||N/A||1966|
|Mr. Michael C. Donegan||Interim CFO, Chief Accounting Officer and Principal Financial & Accounting Officer||N/A||N/A||1968|
|Ms. Daniella Silva||Chief Compliance Officer||N/A||N/A||1986|
|Mr. Benjamin Foulk||VP of HR||N/A||N/A||1970|
|Mr. Mitchell L. Krassan||Exec. VP and Chief Strategy & Performance Officer||N/A||N/A||1966|
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
TherapeuticsMD, Inc.’s ISS governance QualityScore as of 1 October 2022 is 5. The pillar scores are Audit: 4; Board: 8; Shareholder rights: 2; Compensation: 5.